Marshall Wace

Marshall Wace’s UroGen Pharma URGN Stock Holding History

Marshall Wace’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,300	Closed	-$382K	–	3715
2025 Q4	$382K	Sell	16,300 -2,375	-13%	-$51.5K	﹤0.01%	2358
2025 Q3	$373K	Sell	18,675 -1,985	-10%	-$35.6K	﹤0.01%	2346
2025 Q2	$283K	Buy	20,660 +9,160	+80%	+$87.9K	﹤0.01%	2344
2025 Q1	$127K	Sell	11,500 -124,991	-92%	-$1.33M	﹤0.01%	2473
2024 Q4	$1.45M	Buy	+136,491	New	+$1.63M	﹤0.01%	1565
2024 Q3	–	Sell	-42,841	Closed	-$719K	–	3008
2024 Q2	$719K	Buy	+42,841	New	+$609K	﹤0.01%	1818
2024 Q1	–	Sell	-28,552	Closed	-$428K	–	2866
2023 Q4	$428K	Buy	28,552 +1,731	+6%	+$22.5K	﹤0.01%	1769
2023 Q3	$376K	Sell	26,821 -60,059	-69%	-$964K	﹤0.01%	1805
2023 Q2	$899K	Buy	86,880 +71,572	+468%	+$790K	﹤0.01%	1763
2023 Q1	$141K	Buy	+15,308	New	+$141K	﹤0.01%	2453
2020 Q1	–	Sell	-1,769	Closed	-$59K	–	2076
2019 Q4	$59K	Buy	1,769 +550	+45%	+$15K	﹤0.01%	1527
2019 Q3	$29K	Buy	+1,219	New	+$39.9K	﹤0.01%	1573

Other funds holding URGN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Toronto Dominion Bank

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

SG Americas Securities

SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return

American Century Companies

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return